Details for New Drug Application (NDA): 021835
✉ Email this page to a colleague
The generic ingredient in CLOBEX is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 021835
Tradename: | CLOBEX |
Applicant: | Galderma Labs Lp |
Ingredient: | clobetasol propionate |
Patents: | 0 |
Pharmacology for NDA: 021835
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 021835
Suppliers and Packaging for NDA: 021835
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLOBEX | clobetasol propionate | SPRAY;TOPICAL | 021835 | NDA | Galderma Laboratories, L.P. | 0299-3849 | 0299-3849-01 | 1 BOTTLE in 1 CARTON (0299-3849-01) / 10 mL in 1 BOTTLE |
CLOBEX | clobetasol propionate | SPRAY;TOPICAL | 021835 | NDA | Galderma Laboratories, L.P. | 0299-3849 | 0299-3849-02 | 1 BOTTLE in 1 CARTON (0299-3849-02) / 59 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY;TOPICAL | Strength | 0.05% | ||||
Approval Date: | Oct 27, 2005 | TE: | AT | RLD: | Yes |
Expired US Patents for NDA 021835
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Galderma Labs Lp | CLOBEX | clobetasol propionate | SPRAY;TOPICAL | 021835-001 | Oct 27, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Galderma Labs Lp | CLOBEX | clobetasol propionate | SPRAY;TOPICAL | 021835-001 | Oct 27, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription